Cargando…

Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma

BACKGROUND: We aim to investigate the potential value of cuproptosis-related lncRNA signaling in predicting clinical prognosis and immunotherapy and its relationship with drug sensitivity in head and neck squamous cell carcinoma (HNSCC). METHODS: We first identified the lncRNAs associated with cupro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Baoai, Li, Shuang, Huang, Shuo, Huang, Jing, Wu, Tingting, Chen, Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576967/ https://www.ncbi.nlm.nih.gov/pubmed/37846311 http://dx.doi.org/10.7717/peerj.16197

Ejemplares similares

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

LncRNA AL161431.1 predicts prognosis and drug response in head and neck squamous cell carcinoma
por: Zhou, Mingzhu, et al.
Publicado: (2023)

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Yang, Liuqing, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer
por: Feng, Anqi, et al.
Publicado: (2022)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

lncRNA SNHG16 is associated with proliferation and poor prognosis of pediatric neuroblastoma
por: Yu, Yongbo, et al.
Publicado: (2019)

The Role of lncRNA Crosstalk in Leading Cancer Metastasis of Head and Neck Squamous Cell Carcinoma
por: Wang, Yu, et al.
Publicado: (2020)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022)

The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
por: Li, Yao jun, et al.
Publicado: (2022)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

A cuproptosis and copper metabolism–related gene prognostic index for head and neck squamous cell carcinoma
por: Zhang, Shuaiyuan, et al.
Publicado: (2022)

Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer
por: Liu, Xiajing, et al.
Publicado: (2022)

Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma
por: Huang, Jingjing, et al.
Publicado: (2022)

SNHG12: An LncRNA as a Potential Therapeutic Target and Biomarker for Human Cancer
por: Tamang, Suraksha, et al.
Publicado: (2019)

LncRNA SNHG7 Mediates the Chemoresistance and Stemness of Breast Cancer by Sponging miR-34a
por: Li, Zhi-hua, et al.
Publicado: (2020)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia
por: Li, Pian, et al.
Publicado: (2022)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)

Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer
por: Kong, Xiaoyu, et al.
Publicado: (2023)

Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma
por: Yang, Bowen, et al.
Publicado: (2019)

Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
por: Li, Xinyan, et al.
Publicado: (2022)

Cuproptosis combines immune landscape providing prognostic biomarker in head and neck squamous carcinoma
por: Shu, Tingting, et al.
Publicado: (2023)

Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma
por: Wang, Chi, et al.
Publicado: (2023)

Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
por: Wang, Fangwei, et al.
Publicado: (2022)

Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator
por: Li, Xinyan, et al.
Publicado: (2022)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
por: Xu, Miaorong, et al.
Publicado: (2022)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023)

Identification of Ferroptosis-Related lncRNA Pairs for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma
por: Wu, Congxiao, et al.
Publicado: (2022)

A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis
por: Xiang, Junwei, et al.
Publicado: (2022)

LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
por: Xiao, Yuhang, et al.
Publicado: (2020)

Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma
por: He, Yingzheng, et al.
Publicado: (2020)

A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma
por: Mo, Xiaocong, et al.
Publicado: (2022)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
por: Pang, Lin, et al.
Publicado: (2023)

A five-cuproptosis-related LncRNA Signature: predicting prognosis, assessing immune function & drug sensitivity in lung squamous cell carcinoma
por: Zhao, Hongtao, et al.
Publicado: (2023)

A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma
por: Luo, Lan, et al.
Publicado: (2022)

The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma
por: Wang, Yujia, et al.
Publicado: (2020)

Construction of a necroptosis‐related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy
por: Zhang, Peixian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_73crni12osju6odsiq4t15k7e3